U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Interlab S.r.l. - 05/07/2015
  1. Warning Letters


Interlab S.r.l.

Interlab S.r.l.

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
 10903 New Hampshire Avenue
Document Control Room - WO66-G609
Silver Spring, MD 20993-0002 

May 7, 2015

Mr. Roberto (NMI) Maggi, President
Interlab S.r.l.
Via Rina Monti, No. 26
Rome, Italy 00155

Dear Mr. Maggi:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter 392347 dated February 28, 2013. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.



Alberto Gutierrez, Ph.D.
Office of In Vitro Diagnostics and
  Radiological Health
Center for Devices and Radiological